1 Blood-Brain Barrier Transport Drugs Market Overview
1.1 Blood-Brain Barrier Transport Drugs Product Scope
1.2 Blood-Brain Barrier Transport Drugs Segment by Type
1.2.1 Global Blood-Brain Barrier Transport Drugs Sales by Type (2020-2026)
1.2.2 Carrier-mediated Transport
1.2.3 Receptor-mediated Transport
1.2.4 Absorptive-mediated Transport
1.2.5 Active Efflux Transport
1.2.6 Others
1.3 Blood-Brain Barrier Transport Drugs Segment by Application
1.3.1 Global Blood-Brain Barrier Transport Drugs Sales Comparison by Application (2020-2026)
1.3.2 Alzheimer’s Disease
1.3.3 Epilepsy
1.3.4 Parkinson’s Disease
1.3.5 Multiple Sclerosis
1.3.6 Hunter’s Syndrome
1.3.7 Brain Cancer
1.3.8 Others
1.4 Blood-Brain Barrier Transport Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Blood-Brain Barrier Transport Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Blood-Brain Barrier Transport Drugs Price Trends (2015-2026)
2 Blood-Brain Barrier Transport Drugs Estimate and Forecast by Region
2.1 Global Blood-Brain Barrier Transport Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Blood-Brain Barrier Transport Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Blood-Brain Barrier Transport Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Blood-Brain Barrier Transport Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Blood-Brain Barrier Transport Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Blood-Brain Barrier Transport Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Blood-Brain Barrier Transport Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Blood-Brain Barrier Transport Drugs Estimates and Projections (2015-2026)
2.4.3 China Blood-Brain Barrier Transport Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Blood-Brain Barrier Transport Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Blood-Brain Barrier Transport Drugs Estimates and Projections (2015-2026)
2.4.6 India Blood-Brain Barrier Transport Drugs Estimates and Projections (2015-2026)
3 Global Blood-Brain Barrier Transport Drugs Competition Landscape by Players
3.1 Global Top Blood-Brain Barrier Transport Drugs Players by Sales (2015-2020)
3.2 Global Top Blood-Brain Barrier Transport Drugs Players by Revenue (2015-2020)
3.3 Global Blood-Brain Barrier Transport Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood-Brain Barrier Transport Drugs as of 2019)
3.4 Global Blood-Brain Barrier Transport Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Blood-Brain Barrier Transport Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Blood-Brain Barrier Transport Drugs Players (Opinion Leaders)
4 Global Blood-Brain Barrier Transport Drugs Market Size by Type
4.1 Global Blood-Brain Barrier Transport Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Blood-Brain Barrier Transport Drugs Price by Type (2015-2020)
4.2 Global Blood-Brain Barrier Transport Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Blood-Brain Barrier Transport Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Blood-Brain Barrier Transport Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Blood-Brain Barrier Transport Drugs Price Forecast by Type (2021-2026)
5 Global Blood-Brain Barrier Transport Drugs Market Size by Application
5.1 Global Blood-Brain Barrier Transport Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Blood-Brain Barrier Transport Drugs Price by Application (2015-2020)
5.2 Global Blood-Brain Barrier Transport Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Blood-Brain Barrier Transport Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Blood-Brain Barrier Transport Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Blood-Brain Barrier Transport Drugs Price Forecast by Application (2021-2026)
6 United States Blood-Brain Barrier Transport Drugs Market Facts & Figures
6.1 United States Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
6.2 United States Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
6.3 United States Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
7 Europe Blood-Brain Barrier Transport Drugs Market Facts & Figures
7.1 Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
7.2 Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
7.3 Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
8 China Blood-Brain Barrier Transport Drugs Market Facts & Figures
8.1 China Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
8.2 China Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
8.3 China Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
9 Japan Blood-Brain Barrier Transport Drugs Market Facts & Figures
9.1 Japan Blood-Brain Barrier Transport Drugs Sales Market Share by Company (3015-3030)
9.2 Japan Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
9.3 Japan Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
10 Southeast Asia Blood-Brain Barrier Transport Drugs Market Facts & Figures
10.1 Southeast Asia Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
11 India Blood-Brain Barrier Transport Drugs Market Facts & Figures
11.1 India Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
11.2 India Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
11.3 India Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Blood-Brain Barrier Transport Drugs Business
12.1 Cyclenium
12.1.1 Cyclenium Corporation Information
12.1.2 Cyclenium Business Overview
12.1.3 Cyclenium Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Cyclenium Blood-Brain Barrier Transport Drugs Products Offered
12.1.5 Cyclenium Recent Development
12.2 BioAdvance
12.2.1 BioAdvance Corporation Information
12.2.2 BioAdvance Business Overview
12.2.3 BioAdvance Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 BioAdvance Blood-Brain Barrier Transport Drugs Products Offered
12.2.5 BioAdvance Recent Development
12.3 EIP Pharma
12.3.1 EIP Pharma Corporation Information
12.3.2 EIP Pharma Business Overview
12.3.3 EIP Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 EIP Pharma Blood-Brain Barrier Transport Drugs Products Offered
12.3.5 EIP Pharma Recent Development
12.4 Bioasis
12.4.1 Bioasis Corporation Information
12.4.2 Bioasis Business Overview
12.4.3 Bioasis Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bioasis Blood-Brain Barrier Transport Drugs Products Offered
12.4.5 Bioasis Recent Development
12.5 Immune Pharmaceuticals
12.5.1 Immune Pharmaceuticals Corporation Information
12.5.2 Immune Pharmaceuticals Business Overview
12.5.3 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Products Offered
12.5.5 Immune Pharmaceuticals Recent Development
12.6 AZ Therapies
12.6.1 AZ Therapies Corporation Information
12.6.2 AZ Therapies Business Overview
12.6.3 AZ Therapies Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 AZ Therapies Blood-Brain Barrier Transport Drugs Products Offered
12.6.5 AZ Therapies Recent Development
12.7 Palobiofarma
12.7.1 Palobiofarma Corporation Information
12.7.2 Palobiofarma Business Overview
12.7.3 Palobiofarma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Palobiofarma Blood-Brain Barrier Transport Drugs Products Offered
12.7.5 Palobiofarma Recent Development
12.8 Bach Pharma
12.8.1 Bach Pharma Corporation Information
12.8.2 Bach Pharma Business Overview
12.8.3 Bach Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bach Pharma Blood-Brain Barrier Transport Drugs Products Offered
12.8.5 Bach Pharma Recent Development
12.9 BrainsGate
12.9.1 BrainsGate Corporation Information
12.9.2 BrainsGate Business Overview
12.9.3 BrainsGate Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 BrainsGate Blood-Brain Barrier Transport Drugs Products Offered
12.9.5 BrainsGate Recent Development
12.10 CarThera
12.10.1 CarThera Corporation Information
12.10.2 CarThera Business Overview
12.10.3 CarThera Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 CarThera Blood-Brain Barrier Transport Drugs Products Offered
12.10.5 CarThera Recent Development
12.11 Dainippon Sumitomo Pharma
12.11.1 Dainippon Sumitomo Pharma Corporation Information
12.11.2 Dainippon Sumitomo Pharma Business Overview
12.11.3 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Products Offered
12.11.5 Dainippon Sumitomo Pharma Recent Development
12.12 Fluorinov Pharma
12.12.1 Fluorinov Pharma Corporation Information
12.12.2 Fluorinov Pharma Business Overview
12.12.3 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Products Offered
12.12.5 Fluorinov Pharma Recent Development
12.13 Fondazione Telethon
12.13.1 Fondazione Telethon Corporation Information
12.13.2 Fondazione Telethon Business Overview
12.13.3 Fondazione Telethon Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Fondazione Telethon Blood-Brain Barrier Transport Drugs Products Offered
12.13.5 Fondazione Telethon Recent Development
12.14 Minoryx
12.14.1 Minoryx Corporation Information
12.14.2 Minoryx Business Overview
12.14.3 Minoryx Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Minoryx Blood-Brain Barrier Transport Drugs Products Offered
12.14.5 Minoryx Recent Development
12.15 NewGen Therapeutics
12.15.1 NewGen Therapeutics Corporation Information
12.15.2 NewGen Therapeutics Business Overview
12.15.3 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.15.4 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Products Offered
12.15.5 NewGen Therapeutics Recent Development
13 Blood-Brain Barrier Transport Drugs Manufacturing Cost Analysis
13.1 Blood-Brain Barrier Transport Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Blood-Brain Barrier Transport Drugs
13.4 Blood-Brain Barrier Transport Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Blood-Brain Barrier Transport Drugs Distributors List
14.3 Blood-Brain Barrier Transport Drugs Customers
15 Market Dynamics
15.1 Blood-Brain Barrier Transport Drugs Market Trends
15.2 Blood-Brain Barrier Transport Drugs Opportunities and Drivers
15.3 Blood-Brain Barrier Transport Drugs Market Challenges
15.4 Blood-Brain Barrier Transport Drugs Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
【掲載企業】
Cyclenium、BioAdvance、EIP Pharma、Bioasis、Immune Pharmaceuticals、AZ Therapies、Palobiofarma、Bach Pharma、BrainsGate、CarThera、Dainippon Sumitomo Pharma、Fluorinov Pharma、Fondazione Telethon、Minoryx、NewGen Therapeutics
【免責事項】
https://www.globalresearch.jp/disclaimer